Form EFFECT Adverum Biotechnologies,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 |
| Accession Number: | 0001193125-25-312792 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sixty North Gold Announces Debt Settlements and Option Grants
- XRP Price Today Faces an Escrow Test as Remittix Confirms Its November 24 RTX Debut
- Digital Asset Custody Market to Hit USD 2.12 Trillion by 2031 as Institutional Adoption, Regulatory Recognition and Tokenized Assets Drive Growth, Says Mordor Intelligence
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
